These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

37 related items for PubMed ID: 3123351

  • 1. CS-514 suppresses plasma triglyceride in hypertriglyceridemic subjects without modifying a lipoprotein structural model.
    Yoshino G, Kazumi T, Iwai M, Kasama T, Iwatani I, Matsuba K, Inui A, Uenoyama R, Yokono K, Otsuki M.
    Horm Metab Res; 1987 Oct; 19(10):513-4. PubMed ID: 3123351
    [No Abstract] [Full Text] [Related]

  • 2. Effect of pravastatin on newly-secreted very low density lipoprotein composition in rats.
    Yoshino G, Matsushita M, Iwai M, Morita M, Matsuba K, Hirano T, Furukawa S, Kazumi T, Baba S.
    Horm Metab Res; 1991 Apr; 23(4):193-5. PubMed ID: 1908431
    [No Abstract] [Full Text] [Related]

  • 3. Effect of CS-514 (pravastatin) on VLDL-triglyceride kinetics in rats.
    Yoshino G, Kazumi T, Kasama T, Iwai M, Iwatani I, Matsuba K, Matsushita M, Baba S.
    Atherosclerosis; 1988 Oct; 73(2-3):191-5. PubMed ID: 3142492
    [Abstract] [Full Text] [Related]

  • 4. Effects of pravastatin and cholestyramine on circulating levels of parathyroid hormone and vitamin D metabolites.
    Ismail F, Corder CN, Epstein S, Barbi G, Thomas S.
    Clin Ther; 1990 Oct; 12(5):427-30. PubMed ID: 2125243
    [Abstract] [Full Text] [Related]

  • 5. Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.
    Franceschini G, Sirtori M, Vaccarino V, Gianfranceschi G, Chiesa G, Sirtori CR.
    J Lab Clin Med; 1989 Sep; 114(3):250-9. PubMed ID: 2504855
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lecithin:cholesterol acyl transfer rate in plasma and its relations to lipoprotein concentrations and to kinetics of bile acids and triglycerides in hyperlipoproteinemic subjects.
    Wallentin L, Angelin B, Einarsson K, Leijd B.
    Scand J Clin Lab Invest Suppl; 1978 Sep; 150():103-10. PubMed ID: 218268
    [No Abstract] [Full Text] [Related]

  • 14. Catabolism of very low density lipoprotein B apoprotein in man.
    Reardon MF, Fidge NH, Nestel PJ.
    J Clin Invest; 1978 Mar; 61(3):850-60. PubMed ID: 205554
    [Abstract] [Full Text] [Related]

  • 15. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
    Brunzell JD, Hazzard WR, Porte D, Bierman EL.
    J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of pravastatin on hepatic metabolism of cholesterol.
    Hellerstein M.
    N Engl J Med; 1991 Jan 10; 324(2):128. PubMed ID: 1898532
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of a new synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on cholesterol synthesis and low density lipoprotein uptake by primary cultures of rat hepatocytes.
    Saito Y, Shiki Y, Shirai K, Yoshida S.
    Arzneimittelforschung; 1988 Feb 10; 38(2):251-3. PubMed ID: 3130840
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 2.